Presentation is loading. Please wait.

Presentation is loading. Please wait.

Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared.

Similar presentations


Presentation on theme: "Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared."— Presentation transcript:

1 Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors Using HLA Typing at 10 Loci  Stefan O. Ciurea, Rima M. Saliba, Gabriela Rondon, Poliana A. Patah, Fleur Aung, Pedro Cano, Borje S. Andersson, Partow Kebriaei, Uday Popat, Marcelo Fernandez-Vina, Richard E. Champlin, Marcos de Lima  Biology of Blood and Marrow Transplantation  Volume 17, Issue 6, Pages (June 2011) DOI: /j.bbmt Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Difference in 3-year OS between matched unrelated donor (n = 318) and 1-antigen/allele mismatch related donor transplants (n = 28) at M.D. Anderson Cancer Center by high-resolution HLA typing at HLA-A, -B, -C, -DRB1, and -DQB1 (P = .04). Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared."

Similar presentations


Ads by Google